Precision Epigenomics

Tucson, United States

Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.

$265K raised

Sep 2025

Debt Financing

Biotechnology Health Diagnostics Medical Oncology

Top Investors

National Institutes of Health

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Precision Epigenomics

How much funding has Precision Epigenomics raised?

Precision Epigenomics has raised $265K in total funding. The most recent round was Debt Financing. The last funding was announced in September 2025.

Who are Precision Epigenomics's investors?

Precision Epigenomics's investors include National Institutes of Health.

Where is Precision Epigenomics headquartered?

Precision Epigenomics is headquartered in Tucson, United States.

What does Precision Epigenomics do?

Precision Epigenomics is a molecular diagnostic company that develops molecular diagnostic assays for cancer diagnosis.

What stage is Precision Epigenomics at?

Precision Epigenomics is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 22, 2025.

MLA

"Precision Epigenomics — Funding & Investors." VCBacked, September 22, 2025, https://www.vcbacked.co/company/precision-epigenomics. Accessed July 2, 2026.

APA

VCBacked. (2025). Precision Epigenomics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/precision-epigenomics

Wikipedia (cite web)

{{cite web |title=Precision Epigenomics — Funding & Investors |url=https://www.vcbacked.co/company/precision-epigenomics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 22, 2025.